心血管

订阅

MedSci主页 / 所有栏目 / 心血管

ACCF/AHA/HRS发布2012版心律失常器械治疗指南

2012-10-03 赵洁慧 译 中国医学论坛报

心律失常心力衰竭
关注

　　美国心脏病学会基金会（ACCF）、美国心脏学会（AHA）和美国心律协会（HRS）近日联合发布了《2012版心律失常器械治疗指南》，对收缩性心力衰竭患者的心脏再同步化治疗（CRT）作了较多更新（表）。9月10日，新版指南同时在线发表于《美国心脏病学会杂志》（J Am Coll Cardiol）、《循环》（Circulation）、《美国心胸外科杂志》（J 

　　美国心脏病学会基金会（ACCF）、美国心脏学会（AHA）和美国心律协会（HRS）近日联合发布了《2012版心律失常器械治疗指南》，对收缩性心力衰竭患者的心脏再同步化治疗（CRT）作了较多更新（表）。9月10日，新版指南同时在线发表于《美国心脏病学会杂志》（J Am Coll Cardiol）、《循环》（Circulation）、《美国心胸外科杂志》（J Thorac Cardiov Sur )和《心律学》（Heart Rhythm）杂志。

　　注： LVEF：左室射血分数；LBBB：左束支传导阻滞；GDMT：指南指导的药物治疗；NYHA：纽约心脏学会。

ACCF/AHA/HRS发布2012版心律失常器械治疗指南

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=5649, encodeId=83ce564915, content=如果能配上指南原文连接就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f5061632, createdName=593799102, createdTime=Thu Apr 18 10:55:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934734, encodeId=a1551934e34bd, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Wed Jul 03 05:06:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267142, encodeId=0e36126e142e1, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324782, encodeId=ae2f1324e8299, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464088, encodeId=3baf1464088b9, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533980, encodeId=2e1b153398001, content=<a href='/topic/show?id=137418191d' target=_blank style='color:#2F92EE;'>#ACCF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1819, encryptionId=137418191d, topicName=ACCF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920412505819, createdName=yinxm8307, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
    2013-04-18 593799102

    如果能配上指南原文连接就更好了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=5649, encodeId=83ce564915, content=如果能配上指南原文连接就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f5061632, createdName=593799102, createdTime=Thu Apr 18 10:55:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934734, encodeId=a1551934e34bd, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Wed Jul 03 05:06:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267142, encodeId=0e36126e142e1, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324782, encodeId=ae2f1324e8299, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464088, encodeId=3baf1464088b9, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533980, encodeId=2e1b153398001, content=<a href='/topic/show?id=137418191d' target=_blank style='color:#2F92EE;'>#ACCF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1819, encryptionId=137418191d, topicName=ACCF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920412505819, createdName=yinxm8307, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
    2013-07-03 w984445tii

    #治疗指南#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=5649, encodeId=83ce564915, content=如果能配上指南原文连接就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f5061632, createdName=593799102, createdTime=Thu Apr 18 10:55:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934734, encodeId=a1551934e34bd, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Wed Jul 03 05:06:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267142, encodeId=0e36126e142e1, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324782, encodeId=ae2f1324e8299, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464088, encodeId=3baf1464088b9, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533980, encodeId=2e1b153398001, content=<a href='/topic/show?id=137418191d' target=_blank style='color:#2F92EE;'>#ACCF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1819, encryptionId=137418191d, topicName=ACCF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920412505819, createdName=yinxm8307, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
    2012-10-05 zhaohui6731

    #AHA#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=5649, encodeId=83ce564915, content=如果能配上指南原文连接就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f5061632, createdName=593799102, createdTime=Thu Apr 18 10:55:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934734, encodeId=a1551934e34bd, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Wed Jul 03 05:06:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267142, encodeId=0e36126e142e1, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324782, encodeId=ae2f1324e8299, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464088, encodeId=3baf1464088b9, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533980, encodeId=2e1b153398001, content=<a href='/topic/show?id=137418191d' target=_blank style='color:#2F92EE;'>#ACCF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1819, encryptionId=137418191d, topicName=ACCF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920412505819, createdName=yinxm8307, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
    2012-10-05 12498568m50暂无昵称

    #ACC#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=5649, encodeId=83ce564915, content=如果能配上指南原文连接就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f5061632, createdName=593799102, createdTime=Thu Apr 18 10:55:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934734, encodeId=a1551934e34bd, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Wed Jul 03 05:06:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267142, encodeId=0e36126e142e1, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324782, encodeId=ae2f1324e8299, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464088, encodeId=3baf1464088b9, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533980, encodeId=2e1b153398001, content=<a href='/topic/show?id=137418191d' target=_blank style='color:#2F92EE;'>#ACCF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1819, encryptionId=137418191d, topicName=ACCF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920412505819, createdName=yinxm8307, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
    2012-10-05 ysjykql

    #HRS#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=5649, encodeId=83ce564915, content=如果能配上指南原文连接就更好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f5061632, createdName=593799102, createdTime=Thu Apr 18 10:55:00 CST 2013, time=2013-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934734, encodeId=a1551934e34bd, content=<a href='/topic/show?id=1072646328c' target=_blank style='color:#2F92EE;'>#治疗指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64632, encryptionId=1072646328c, topicName=治疗指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6732482, createdName=w984445tii, createdTime=Wed Jul 03 05:06:00 CST 2013, time=2013-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267142, encodeId=0e36126e142e1, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1324782, encodeId=ae2f1324e8299, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1464088, encodeId=3baf1464088b9, content=<a href='/topic/show?id=da7d9119bc' target=_blank style='color:#2F92EE;'>#HRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9119, encryptionId=da7d9119bc, topicName=HRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=259a6588710, createdName=ysjykql, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1533980, encodeId=2e1b153398001, content=<a href='/topic/show?id=137418191d' target=_blank style='color:#2F92EE;'>#ACCF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1819, encryptionId=137418191d, topicName=ACCF)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920412505819, createdName=yinxm8307, createdTime=Fri Oct 05 01:06:00 CST 2012, time=2012-10-05, status=1, ipAttribution=)]
    2012-10-05 yinxm8307

    #ACCF#

    0

相关资讯

CRT-D较IST减少不当电击治疗率

　　2012年世界心脏病学大会(4月18～21日，阿联酋迪拜）上报告的英国学者的一项研究。研究人员发现：置入心脏再同步治疗装置（CRT-D）病人的不当电击治疗（IST）发生率显著低于接受植入型心律转复除颤器（ICD）的病人，这可能缘于房性心律失常负担的减少，尚需要进一步研究来评估心脏再同步治疗是否能减少房性心律失常的发生率。 　　尽管ICD有益，但仍有相当数量的病人在植入后经历IST。越来越多数

阵发性心房颤动伴快慢综合征——病窦综合征的再认识

    态窦房结综合征（Sick sinus syndrome, SSS），简称病窦，指窦房结及其邻近组织发生病变，导致窦房结的冲动形成障碍和/或冲动传出障碍，从而引起一系列心律失常，其临床表现是以缓慢性窦性心律失常为基础而产生的头晕、晕厥等症状，同时也可在此基础上表现出多种快速性心律失常，如阵发性房性心动过速（房速）、心房扑动（房扑）、心房颤动（房颤）等。 &nbs

Circulation：多项指标与先心病心脏猝死相关

　　9月18日《循环》杂志（Circulation）在线发表一项关于先心病成年患者心脏猝死的研究，结果提示，先心病（CHD）成年患者发生心脏猝死（SCD）的相关临床指标范围较广，其中包括系统性右室功能。此外，即使轻度心脏受损的患者也有发生SCD的可能性。 　　多中心病例对照研究，对象为已确诊或推测因心律失常猝死的患者。根据诊断、手术类型、年龄和性别给每1例患者匹配2例病例对照。3个数据库中共有2

警惕！血液透析引起相关心律失常

解放军总医院老年肾内科 程庆砾           血液透析（HD）相关心律失常是指患者在血液透析治疗开始前无心律失常的病史，而在HD 治疗开始以后出现的心律失常，或在血液透析前已经出现某一种心律失常的基础上又出现了另外一种类型心律失常的临床表现。     发生率    &nbs

Circulation：疤痕相关室性心动过速（VT）改良新终点

　　研究显示，对于疤痕相关的室性心动过速（VT），明确局部异常心室活动（LAVA）并消除LAVA 是安全可行的，患者存活率更高，且可避免VT复发。该研究2012年4月4日在线发表于《循环》（Circulation）杂志。 　　导管消融治疗VT有效，而且在需要经常除颤的患者中特别有用，对于不能描记的或血流动力学不耐受的VT，有各种不同的基质改良技术。非诱导性是最常被使用的VT终点，但其有

HRS:心房超速起搏预防房颤效果欠佳

       德国J.W.歌德大学的Stefan Hohnloser博士在心律学会(HRS)年会上报告，持续心房超速起搏(CAOP)并不能预防新发房颤，对于无房颤病史的患者而言没有价值。        迄今已有24项中小型研究在1万多例患者中评估了预防性房颤起搏的效果，但由于随访时间较短、所使用的起搏器品牌和参数